Pharmafile Logo
Pharmafocus logo
Advanced Search
novo_flag

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017
Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

News

Juno Therapeutics bring in new executive vice president

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

Appointment
revlimid_celgene

Celgene’s Revlimid scores first-of-its-kind myeloma indication in EU

January 27, 2017
Sales and Marketing Celgene, Revlimid, multiple myeloma

Celgene’s Revlimid (lenalidomide) has become the first licensed monotherapy treatment for newly diagnosed multiple myeloma in patients who have undergone …

News
verily_company_logo

Google’s life sciences business gains $800 million funding in pivot to Asia

January 27, 2017
Medical Communications, Sales and Marketing China, Temasek, Verily, google

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

News
money-256281_960_720

Five most talked about mergers and acquisitions of 2016

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

Feature
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

News
mr

Innovative routes to market: Rethinking the life sciences distribution model

January 27, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Deloitte, distribution

Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …

News
celgene_1_02

Celgene to acquire Delinia in a potential $775 million deal

January 27, 2017
Medical Communications Celgene, Delinia

Celgene has shelled out $300 million upfront, with a potential further $475 million in milestone payments, for Delinia, an autoimmune …

News
shutterstock_110597087-web

Skin cancer-detecting AI “on par with board-certified dermatologists”

January 27, 2017
Medical Communications, Research and Development AI, Cancer, skin cancer

New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …

News
teva

Teva agrees $225 million fee in antitrust case

January 27, 2017
Medical Communications Barr Laboratories, Teva, fine

Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …

News
richard_bungay

New CFO for Diurnal

January 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Richard Bungay has been named as the new chief financial officer (CFO) of Diurnal; he has succeeded former CFO Ian …

Appointment
imbruvica_logo_0

NICE approves Imbruvica for second-line leukaemia treatment

January 26, 2017
Medical Communications, Sales and Marketing AbbVie, CLL, Janssen, ibrutinib, imbruvica

NICE has issued its Technology Appraisal Guidance (TAG) that has recommend Imbruvica (ibrutinib) for the treatment of chronic lymphocytic leukaemia …

News
leukamia

Two infants in remission from leukaemia after CAR T-Cell therapy

January 26, 2017
Research and Development

Researchers at the Great Ormond Street Hospital have published the successful treatment of two infants suffering from leukaemia by treatment …

News
currency-166422_960_720

India’s NPPA slashes essential drug prices by up to 50%

January 26, 2017
Sales and Marketing India, nppa, pricing

India’s governmental regulatory agency, the National Pharmaceutical Pricing Authority (NPPA), has addressed the pricing of 33 medicines including antibiotics and …

News
pharma_pill_manufacturing

Jazz Pharmaceuticals UK supplier hit with FDA warning

January 26, 2017
Manufacturing and Production Erwinaze, Porton Biopharma, jazz pharmaceuticals

UK-based Porton Biopharma, supplier of Irish company Jazz Pharmaceuticals’ leukaemia treatment Erwinaze, has been slapped with an FDA warning letter …

News
jj

J&J finally seals $30 billion deal for Actelion

January 26, 2017
Sales and Marketing Actelion, Janssen, Johnson & Johnson

Johnson & Johnson has, as expected, wrapped up the deal to acquire Actelion in a deal worth $30 billion, working …

News
regeneron

Regeneron agrees ownership of HQ for $720m after 25 years

January 25, 2017
Manufacturing and Production, Medical Communications Regeneron

After leasing the property for 25 years, Regeneron has agreed to take ownership of its headquarters and buy the Landmark …

News

Hospira in US-wide recall of product due to contamination

January 25, 2017
Medical Communications Contamination, Hospira, Pfizer

Hospira, a company owned by Pfizer, has been forced to recall a batch of injectable drugs due to “the presence …

News
peter_wheatley_price

Takeda UK names new market access director

January 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …

Appointment

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017
Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026